معرفی
Dr. Amy Hanna is a Postdoctoral Research Fellow at the Institute for Molecular Bioscience (IMB), focusing on molecular mechanisms underlying cardiovascular and muscle disorders. Her research integrates biochemistry, genetics, and metabolomics to investigate diseases such as dilated cardiomyopathy, malignant hyperthermia, and skeletal muscle channelopathies.
Key research areas include calcium signaling pathways, ion channel dysfunction, and the role of genetic mutations in disease pathology. She employs rodent models, metabolomics profiling, and advanced imaging techniques like MyoSight for skeletal muscle analysis.
Her recent work explores therapeutic interventions targeting RyR1/RyR2 channels and TRPV1 variants, alongside the effects of chemotherapeutic agents (e.g., doxorubicin) on cardiac function. Collaborations involve molecular modeling and drug development initiatives.
